[1] |
Atherton DJ. Topical corticosteroids in atopic dermatitis ⁃ Recent research reassures that they are safe and effective in the medium term[J]. BMJ, 2003, 327(7421): 942⁃943. DOI: 10.1136/bmj.327. 7421.942.<br />
|
[2] |
何威. 特应性皮炎外用激素疗法的规范[J]. 中国医学文摘(皮肤科学), 2016, 33(2): 184⁃188.<br />
|
[3] |
Krejci⁃Manwaring J, Tusa MG, Carroll C, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis[J]. J Am Acad Dermatol, 2007, 56(2): 211⁃216. DOI: 10.1016/j.jaad.2006.05.073.<br />
|
[4] |
Aubert⁃Wastiaux H, Moret L, Le RA, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency[J]. Br J Dermatol, 2011, 165(4): 808⁃814. DOI: 10. 1111/j.1365⁃2133.2011.10449.x.<br />
|
[5] |
申春平, 邢嬛, 马琳. 特应性皮炎患儿118例及其家庭生活质量的调查[J]. 中国皮肤性病学杂志, 2010, 24(9): 841⁃843.<br />
|
[6] |
Patel NU, D′Ambra V, Feldman SR. Increasing adherence with topical agents for atopic dermatitis[J]. Am J Clin Dermatol, 2017, 18(3): 323⁃332. DOI: 10.1007/s40257⁃017⁃0261⁃5.<br />
|
[7] |
Wollenberg A, Bieber T. Proactive therapy of atopic dermatitis⁃⁃an emerging concept[J]. Allergy, 2009, 64(2): 276⁃278. DOI: 10. 1111/j.1398⁃9995.2008.01803.x.<br />
|
[8] |
Wollenberg A, Reitamo S, Atzori F, et al. Proactive treatment of atopic dermatitis in adults with 0.1 tacrolimus ointment[J]. Allergy, 2008, 63(6): 742⁃750. DOI: 10.1111/j.1398⁃9995.2008. 01683.x.<br />
|
[9] |
Thaçi D, Reitamo S, Gonzalez EMA, et al. Proactive disease management with 0.03 tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, compara⁃tive study[J]. Br J Dermatol, 2008, 159(6): 1348⁃1356. DOI: 10. 1111/j.1365⁃2133.2008.08813.x.<br />
|
[10] |
梁源, 刘玲玲. 外用钙调神经磷酸酶抑制剂在特应性皮炎中的应用[J]. 中国医学文摘(皮肤科学), 2016, 33(2): 189⁃194.<br />
|
[11] |
Nicol NH, Boguniewicz M. Wet wrap therapy in moderate to severe atopic dermatitis[J]. Immunol Allergy Clin North Am, 2017, 37(1): 123⁃139. DOI: 10.1016/j.iac.2016.08.003.<br />
|
[12] |
王珊, 马琳. 湿包裹治疗13例儿童重度特应性皮炎临床效果观察[J]. 中华皮肤科杂志, 2017, 50(11): 832⁃834. DOI: 10.3760/cma.j.issn.0412⁃4030.2017.11.013.<br />
|
[13] |
Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents[J]. J Am Acad Dermatol, 2014, 71(2): 327⁃349. DOI: 10.1016/j.jaad.2014.03.030.<br />
|
[14] |
Patrizi A, Raone B, Ravaioli GM. Safety and efficacy of photo⁃therapy in the management of eczema[J]. Adv Exp Med Biol, 2017, 996: 319⁃331. DOI: 10.1007/978⁃3⁃319⁃56017⁃5_27.<br />
|
[15] |
Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhance⁃ment of the skin barrier from birth offers effective atopic dermatitis prevention[J]. J Allergy Clin Immunol, 2014, 134(4): 818⁃823. DOI: 10.1016/j.jaci.2014.08.005.<br />
|
[16] |
Horimukai K, Morita K, Narita M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis[J]. J Allergy Clin Immunol, 2014, 134(4): 824⁃830. e6. DOI: 10.1016/j.jaci.2014.07.060.<br />
|
[17] |
Bertelsen RJ, Brantsæter AL, Magnus MC, et al. Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases[J]. J Allergy Clin Immunol, 2014, 133(1): 165⁃171. e1⁃8. DOI: 10.1016/j.jaci.2013.07.032.<br />
|
[18] |
Wickens K, Black P, Stanley TV, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years[J]. Clin Exp Allergy, 2012, 42(7): 1071⁃1079. DOI: 10.1111/j.1365⁃2222.2012.03975.x.<br />
|
[19] |
Boyle RJ, Bath⁃Hextall FJ, Leonardi⁃Bee J, et al. Probiotics for treating eczema[J]. Cochrane Database Syst Rev, 2008, (4): CD006135. DOI: 10.1002/14651858.CD006135.pub2.<br />
|
[20] |
Fiocchi A, Burks W, Bahna SL, et al. Clinical use of probiotics in pediatric allergy (CUPPA): a world allergy organization position paper[J]. World Allergy Organ J, 2012, 5(11): 148⁃167. DOI: 10.1097/WOX.0b013e3182784ee0.<br />
|
[21] |
向娟, 王华. 特应性皮炎与维生素D[J]. 中国医学文摘(皮肤科学), 2016, 33(2): 133⁃137.<br />
|